Biofourmis raises $100 million for AI remote medical tools

Biofourmis, an AI health IT company based in Singapore, today announced it raised $100 million in a series C funding round led by SoftBank’s Vision Fund 2. CEO Kuldeep Singh Rajput said the company will use the proceeds to accelerate expansion, advance therapeutics pipelines, develop care pathways, and drive integration with health system, hospital, pharmaceutical, and research clients.